Loading…
Based on limited metadata, this FDA Warning Letter was issued to Centurion Laboratories Private Limited, a pharmaceutical manufacturer, on May 4, 2019. Without access to the full letter text or subject line, the specific nature of the drug manufacturing violations cannot be determined from the available information. The warning pertains to drug products under FDA jurisdiction, though the specific issuing office is not identified in the metadata provided. To understand the particular compliance issues cited, the complete warning letter would need to be reviewed.